Clik here to view.
NeuroMetrix shares slump after clearing 1-for-4 split
NeuroMetrix (NSDQ:NURO) said today it consummated its 1 for 4 reverse split of its common stock, trading at a split-adjusted basis yesterday. Stocks rose on Tuesday to open at $3.01, but dropped to...
View ArticleClik here to view.
Dehaier Medical mulls takeover bid
Dehaier Medical said today it received a $20 million equity investment offer from Hangzhou Liaison Interactive Information Technology for 10 million newly issued common shares at $2 per share....
View ArticleClik here to view.
AdvanSource taps Mirus for ‘strategic alternatives’
AdvanSource Biomaterials said today it tapped Boston-based investment bank Mirus Securities to help provide guidance to the company. Wilmington, Mass.-based Advansource Biomaterials manufactures...
View ArticleClik here to view.
Procept BioRobotics launches AquaBeam trial
Procept BioRobotics said today it treated the 1st patients in a clinical trial of its AquaBeam water ablation therapy system designed to treat prostate disease. The Water study is a phase III clinical...
View ArticleClik here to view.
Learning about treating muscular dystrophy from an unusual golden retriever
Ringo was a golden retriever that defied the odds. Despite having the gene mutation for Duchenne muscular dystrophy (DMD), he remained healthy. And he’s provided a new lead for boosting muscle strength...
View ArticleClik here to view.
Senate votes to repeal medical device tax
The U.S. Senate yesterday passed a bill that would gut key provisions of the Affordable Care Act and do away with the medical device tax, but the measure faces certain death as soon as it hits...
View ArticleClik here to view.
Bard, Boston Scientific in 1st trial against 2 pelvic mesh makers
A trial is under way in Kansas City in a product liability lawsuit against Boston Scientific (NYSE:BSX) and C.R. Bard (NYSE:BCR), marking the 1st time a pelvic mesh lawsuit against 2 companies has gone...
View ArticleClik here to view.
Medtronic mulls sale of some Covidien assets
With 3 quarters of operations under its belt since the $50 billion acquisition of Covidien, Medtronic (NYSE:MDT) is evaluating whether to sell off some of the Covidien assets, CEO Omar Ishrak told...
View ArticleClik here to view.
Medtronic finally escapes Lenox MacLaren bone mill suit
A federal judge in Colorado dismissed an anti-trust lawsuit filed against Medtronic (NYSE:MDT) by bone mill maker Lenox MacLaren Surgical, ruling that Lenox failed to name the correct Medtronic...
View ArticleClik here to view.
B. Braun gets into managed care with First Databank
B. Braun Medical said yesterday it will offer clinical support and managed care resources for and infusion pump drug library through a collaboration with First Databank. Bethlehem, Penn.-based B....
View ArticleClik here to view.
Conmed acquires KFx’s AppianFx soft tissue fixation device
KFx Medical said today that ConMed (NSDQ:CNMD) acquired its AppianFx soft tissue fixation device for an undisclosed amount. “The AppianFx system fits perfectly within the broad sports medicine Conmed...
View ArticleClik here to view.
Siemens Healthcare leaves Pittsburgh for Cleveland
Siemens Healthcare (NYSE:SI) said today it is moving its central zone headquarters from Pittsburgh, Penn. to the Global Center for Health Innovation in Cleveland, Ohio. The move will position the...
View ArticleClik here to view.
Medtech approvals: FDA releases October 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in October 2015: Summary of PMA Originals & Supplements Approved Originals: 9 Supplements: 133 Summary of...
View ArticleClik here to view.
Gore wins round in stent graft bout with Bard
W.L. Gore & Associates won a round against C.R. Bard (NYSE:BCR) in an ongoing stent graft patent validity battle as a Delaware federal judge upheld the validity of 2 Gore stent graft patents. The...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for December 4, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
Qfix wins FDA 510(k) for SRS immobilization device
Radiotherapy patient positioning device manufacturer Qfix said today it won FDA 510(k) clearance for its Encompass stereotactic radiosurgery immobilization system. The Encompass imobilization system...
View ArticleClik here to view.
Novocure touts preliminary data on tumor treating fields.
NovoCure (NSDQ:NVCR) said yesterday that a retrospective analysis of its Tumor Treating Fields therapy showed it safe in adult glioblastoma patients with implanted non-programmable shunts. The FDA...
View ArticleClik here to view.
EU OKs add’l delivery cath for InspireMD’s CGuard stent
InspireMD (OTC:NSPR) said Wednesday it won European Union regulatory approval, including CE Mark approval, for the manufacturing and commercialization of its CGuard stent delivery catheter. The...
View ArticleClik here to view.
Mynosys wins CE Mark for Zepto capsulotomy device
Mynosys Cellular Devices said yesterday it won CE Mark approval in the European Union for its Zepto device for performing anterior lens capsulotomies during cataract surgery. The device is designed to...
View ArticleClik here to view.
Mercury Biomed wins $1.4m grant for thermal body tech
Newly formed medical temperature management company Mercury Biomed said Wednesday it won a $1.4 million loan from the Ohio Third Frontier Commercialization Acceleration Loan Fund for its Smart...
View Article